Trade name – Veenat 100 Imatinib.
Active substance – Imatinib (imatinib mesilate).
Quantity in package-120 capsules.
Manufacturer – Natco Pharma LTD (India).
Anticancer drug Veenat 100 (generic drug Glivec), the Indian company Natco, was appointed by the doctors for the following diseases: malignant stromal tumor, chronic myeloid leukemia in all phases. With Veenat may be appointed as “naive” patients (not previously treated), and “null responders” (patients who were treated with interferon alpha, but got no positive results). Imatinib mesylate – the main component of the drug at a dose of 100 mg has a selective effect on the proliferation of cancer cells that progressively leads to their death, you can buy anticancer medicine imatinib veenat 100mg from India.
— first identified positive for the Philadelphia chromosome (Ph+) chronic myeloid leukemia (CML) in children and adults;
– Ph+ CML in chronic phase in case of failure of previous therapy with interferon alpha or in acceleration phase, or blast crisis in children and adults;
— newly diagnosed Philadelphia positive chromosome (Ph+) acute lymphoblastic leukemia (ALL) in adult patients in combination with chemotherapy;
– recurrent or refractory Ph+ ALL in adult patients as monotherapy;
– myelodysplastic / myeloproliferative diseases associated with gene rearrangements of platelet growth factor receptor in adult patients;
– systemic mastocytosis in adult patients with no d816v C-kit mutation or with unknown C-Kit mutation status;
– hypereosinophilic syndrome and / or chronic eosinophilic leukemia in adults with positive or negative abnormal FIP1L1-PDGRF alpha-tyrosine kinase;
an inoperable and/or metastatic malignant gastrointestinal stromal tumors positive for c-Kit (CD 117) in adult patients;
– adjuvant therapy of C-Kit (CD 117) positive gastrointestinal stromal tumors in adult patients;
– inoperable, recurrent and / or metastatic swelling dermatofibrosarcoma in adult patients.
Statistics in the treatment Of imatinib of patients who have not previously received other treatment, such is:
95% – onset of complete hematological remission;
76% — the onset of complete cytogenetic remission;
93% – no progression of the disease;
A 90% survival rate;
84% – no relapse;
4-5% – cancellation of the drug due to the development of severe side effects.
Do not forget that there is no ideal medicine, because each individual case of the disease proceeds differently. That is why there is a group of people who develop resistance, so therapy becomes ineffective. Others have intolerance to the active substance.
You can buy Veenat 100 Imatinib in online pharmacies or from official representatives of the manufacturer of this drug company, which most often also work through the Internet.